ANGIOPLASTY SUMMIT TCTAP 2013, April 23-26, Seoul, Korea
  1. Takeshi K: Anticoagulant and Antiplatelet Therapy in Patients with Atrial Fibrillation Undergoing PCI.
  2. Higami H: A case of Acute Coronary Syndrome with Abdominal Aortic Stenosis.
  3. Tazaki J, Higami H, Imai M, Saito N, Kimura T: Successful
  4. Revascularization of BK Lesion With Dorsal Puncture For CLI Patient.
International Symposium of Aldosterone and Related Substances in Hypertension 2013, April 27-28, Sendai
  1. Yamada C, Kuwahara K, Kinoshita H,Nishikimi T,Nakagawa Y, Kuwabara Y,Nakao K, Nakao K: Inhibition of renin-angiotensin system potently prevents arrhythmogenic left ventricular remodeling and sudden cardiac death in mice with dilated cardiomyopathy.
International Society for Stem Cell Research(ISSCR) 11th Annual Meeting, June 12-15, Boston
  1. Funakoshi S, Yoshida Y, Makiyama T, Kimura T, Yamanaka S: A Disease Model of Familial Hypertrophic Cardiomyopathy using Patient-Specific Induced Pluripotent Stem Cells.
EHRA EUROPACE 2013, June 23-26, Athens, Greece
  1. Yahata M: The impact of supraventricular tachyarrhythmia on the long-term clinical outcome in patients undergoing cardiac resynchronization therapy: Insight from the CUBIC registry.
18th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy, June 28-30, Roma, Italy
  1. Horie T, Baba O, Nishiga M, Hasegawa K, Yokode M, Kimura T, Ono K: MicroRNA-33 deficiency reduces atherosclerosis formation in vivo.
4th DIA Cardiac Safety Workshop in Japan, July 11-12, Tokyo
  1. Ono K: Use of miRNA for the Detection of Cardiotoxicity.
Gordon Reseach Conferences, Biology of Aging, August 11-16, Lucca, Italy
  1. Tanada Y, Shioi T, Kawamoto A, Okuda J, Kimura T: Branched–chain amino acids prevent heart failure in rats.
Cold spring harbor laboratory meeting. Regulatory and non-coding RNA, August 13-17, NY
  1. Ono K: Cardiac-specific inhibition of kinase activity in calcium/calmodulin-dependent kinase kinase-b leads to accerelated left ventricular remodeling and heart failure after transverse aortic constriction in mice.
  2. Kuwabara Y: LincRNAs regulated by pressure-overload induce hypertrophy in neonatal mouse ventricular cardiomyocytes.
  3. Nishino T: MicroRNA-33a, embedded in Srebf2 gene, regulates lipogenic pathway in vivo.
2013年欧州心臓学会議 (ESC 2013), August 31-September 4, Amsterdam, Netherland
  1. Yano M: Antiplatelet Therapy Discontinuation and Stent Thrombosis After Sirolimus-Eluting Stent Implantation: Five-year Outcome of the j-Cypher Registry.
  2. Imai M, Kimura T, Morimoto T, Saito N, Shiomi H, Kawaguchi R, Kan H, Mukawa H, Fujita H, Ishise T, Hayashi F, Nagao K, Take S, Taniguchi H, Sakamoto H, Yamane T, Shirota K, Tamekiyo H, Okamura T, Kishi K, Miyazaki S, Yamamoto S, Yamaji K, Kawasaki T, Taguchi E, Nakajima H, Kosedo I, Tada T, Kadota K, Mitsudo K: Characteristics of Angiographic Peri-Stent Contrast Staining (PSS) on Very Late Stent Thrombosis After Sirolimus-Eluting Stent Implantation: Morphological Classification and Antiplatelet Therapy.
  3. Shiomi H: CREDO-Kyoto Registry: Trends over the Past Decade in Therapeutic Strategies and Long-term Outcome of Patients Undergoing Coronary Revascularization in Japan.
  4. Nakagawa Y, Nishikimi T, Kuwahara K, Yasuno S, Kinoshita H, Kuwabara Y, Yamada C, Nakao K, Ueshima K, Nakao K: Effect of hemodyalysis on precursor proBNP and glycosylated NT-proBNP in end-stage renal disease patients.
  5. Higami H: Five-year outcomes and late adverse events after sirolimus-eluting stent implantation for unprotected left main coronary artery disease.
International Conference on Endothelin ET-13, September 8-11, Tokyo
  1. Kinoshita H, Kuwahara K, Nishida M, Kurose H, Kiyonaka S, Mori Y, Yamada C, Kuwabara Y, Yasuno S, Nakagawa Y, Nishikimi T, Ueshima K, Nakao K: Blockade of TRPC6 is a Novel Therapeutic Approach Against Pathological Cardiac Remodeling.
The 6th Asia-Pacific Heart Rhythm Society (APHRS) Scientific Session, October 3-6th, Hong Kong, China
  1. Wuriyanghai Y: Identification of Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells using a Cardiac Specific Promoter Lentiviral Vector.
  2. Chen J: Cardiac sodium channel mutation may induce epinephrine/exercise triggered QT prolongation.
  3. Nishiuchi S: Lamin A/C Related Cardiomyopathy due to the R377R Synonymous Mutation Causing the Splicing Abnormality.
  4. Harita T: SCN5A mutations associated with familial atrial fibrillation without structural heart diseases.
  5. Hayano M: SCN5A mutations associated with Dilated Cardiomyopathy.
Venice Arrhythmias 2013, October 27-29, Venice, Italy
  1. Yamazaki M, Honjo H,Kodama I, Nakagawa Y, Kuwahara K, Kamiya K: Mechanisms of lethal arrhythmias in a transgenic mouse model with heart failure and sudden cardiac death.
平成25年度新学術領域「転写代謝システム」第5回総括班会議 国際シンポジウム“International Symposium on Transcription and Metabolism”, November 11-13, 淡路
  1. Ono K: MicroRNA encoded by an intron of Srebf2 regulates SREBP-1 in vivo.
  2. Horie T: MicroRNA encoded by an intron of Srebf2 regulates SREBP-1 in vivo.
  3. Kuwabara Y: MicroRNA-451 Exacerbates Lipotoxicity in Cardiomyocytes and High-Fat Diet-Induced Cardiac Hypertrophy in Mice through Suppression of the LKB1/AMPK Pathway.
American Heart Association Annual Scientific Sessions 2013, November 16-22, Dallas
  1. Kuwabara Y: LincRNAs regulated by pressure-overload induce hypertrophy in neonatal mouse ventricular cardiomyocytes.
  2. Nishikimi T, Nakagawa Y, Minamino N, Ikeda M, Ishimitsu T, Yamada C, Nakao K, Minami T, Kuwabara Y, Kinoshita H, Kangawa K, Kuwahara K, Nakao K: O-glycosylated Pro B-type Natriuretic Peptide is Cleaved intracellularly By Furin in Ventricular Myocytes and Atrial Myocytes: Importance of the Distance Between the O-glycosylation Sites and Cleaved Sites.
  3. Tanada Y, Shioi T, Kawamoto A, Okuda J, Kimura T: Branched-chain amino acids ameliorate heart failure in rats.
  4. Nishi K, Sato Y, Ohno M, Hiraoka Y, Saijyo S, Sakamoto J, Chen P, Kita T, Inagaki N, Kimura T, Nishi E: Nardilysin is a critical regulator of insulin secretion and glucose metabolism.
  5. Funakoshi S, Yoshida Y, Makiyama T, Kimura T, Yamanaka S: Cell Cycle Activation of Hypertrophic Cardiomyopathy: Insights From Research of Patient-Specific Induced Pluripotent Stem Cells-Derived Cardiomyocytes.
  6. Sasaki K: Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Human Induced Pluripotent Stem Cells: A Promising Tool for Drug Discovery.
  7. Goto K, Shizuta S, Nakai K, Morimoto T, Shiomi H, Natsuaki M, Nakagawa Y, Furukawa Y, Kimura T: Impact of Renal Dysfunction on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention who have Concomitant Atrial Fibrillation: From the CREDO-Kyoto Registry Cohort-2.
The 7th Cachexia conference, December 9-11, Kobe
  1. Tanada Y, Shioi T, Kawamoto A, Okuda J, Kimura T: Branched-chain amino acids prevent cardiac cachexia in rats.
American Society for Cell Biology(ASCB), December 14-18, New Orleans
  1. Hiraoka Y, Matsuoka T, Ohno M, Nishi K, Nakamura K, Kita T, Kimura T, Nishi E: Critical roles of a metalloendopeptidase nardilysin in cold-induced adaptive thermogenesis.
The Leipzig Interventional Course(LINC) 2014, January 28-31, Leipzig
  1. Tazaki J, Higami H, Higashitani N, Imai M, Watanabe S, Saito N, KimuraT: Mid-term Outcome of Branched Inoue Stent Graft for Thoracic Aortic Aneurysm and Dissections.
The American College of Cardiology(ACC) 63rd Annual Scientific Session, March 29-31, Washington, D.C.
  1. Toyota T, Shiomi H, Taniguchi T, Nakatsuma K, Watanabe H, Ono K, Shizuta S, Makiyama T, Nakagawa Y, Furukawa Y, Ando K, Kadota K, Horie M, Kimura T: Prognostic Impact of the Staged Percutaneous Coronary Intervention Strategy for Non-Culprit Lesions in ST-Segment Elevation Myocardial Infarction Patients with Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention.
  2. Taniguchi T, Toyota T, Shiomi H, Nakatsuma K, Watanabe H, Makiyama T, Shizuta S, Morimoto T, Furukawa Y, Nakagawa Y, Horie M, Kimura T: Preinfarction Angina Predicts Better 5-Year Outcomes in Patients with ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
  3. Watanabe H, Morimoto T, Kimura T: Relation of Antiplatelet Therapy Discontinuation after Coronary Stenting with the Risk of Adverse Cardiovascular Events: Observation from the CREDO-Kyoto PCI/CABG Registry Cohort-2.